Cleared Traditional

K220631 - NomadAir PMU810

K220631 is an FDA 510(k) clearance for NomadAir PMU810, manufactured by Neurotronics, Inc.. The device is a Class 2 Neurology device with product code GWL cleared through the Traditional 510(k) pathway after a 133-day FDA review.

K220631 · Neurotronics, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2022
Decision
133d
Days
Class 2
Risk

K220631 is an FDA 510(k) clearance for the NomadAir PMU810. Classified as Amplifier, Physiological Signal (product code GWL), Class II - Special Controls.

Submitted by Neurotronics, Inc. (Gainesville, US). The FDA issued a Cleared decision on July 15, 2022 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1835 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Neurotronics, Inc. devices

FDA 510(k) Submission Details - K220631

510(k) Number K220631 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 04, 2022
Decision Date July 15, 2022
Days to Decision 133 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
15d faster than avg
Panel avg: 148d · This submission: 133d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWL Device Classification - Class 2, Special Controls

Product Code GWL Amplifier, Physiological Signal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1835
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWL Amplifier, Physiological Signal

All 18
Devices cleared under the same product code (GWL) and FDA review panel - the closest regulatory comparables to K220631.
X-trodes System M
K232210 · X-Trodes · Feb 2024
Vlab
K230148 · Dormotech Medical, Ltd. · Oct 2023
SomniCheck
K223676 · Brainmatterz, LLC · Jun 2023
Quick-20m
K203331 · Cgx, LLC · May 2021
Digital NeuroPort Biopotential Signal Processing System
K202174 · Blackrock Microsystems · Feb 2021
8-CH Electroencephalography Amplifier
K201747 · Hipposcreen Neurotech Corp. · Dec 2020